ATLANTA, Aug. 9, 2024 /PRNewswire/ -- Core Access Surgical
Technologies, Inc. (CAST) is pleased to announce that its
innovative CAST LevaLap® 1.0 will be presented at
the 2024 American Association of Gynecologic Laparoscopists (AAGL)
53rd Global Congress on MIGS, held in New
Orleans, Louisiana, from Nov. 16-19,
2024. The Abstract for LevaLap® 1.0 has been
accepted for oral presentation to the attendees of this prestigious
event.
After rigorous peer review and criteria for inclusion at the
Global Congress, CAST has been chosen to unveil the breakthrough
data of the company's Post Market Clinical Follow-Up Study for
LevaLap® 1.0. The study featured a world-class group of
key physician opinion leaders and hospitals across six countries
and eight medical centers, both university and major private
centers. This underscores CAST's commitment to advance surgical
access solutions, appropriately test and evaluate them, and to
support the global medical community.
The innovation behind LevaLap® incorporates a
significant advancement in speed and efficiency of precise
laparoscopic access, offering new opportunities for standardized
abdominal entry. This advancement is set to transform the landscape
of minimally invasive laparoscopic entry across multiple fields,
including gynecology, urology, general surgery, and robotic
surgery.
"The honor of presenting our data is a significant milestone for
everyone at CAST Surgical. LevaLap® 1.0 is our inaugural
solution, and CAST's team of experts have begun attending top
educational congresses around the world to continue the discussion
with the medical community. The good news we are sharing with the
world is a device that offers stable and more precise laparoscopic
access is here now." – Thomas A.
Gordy, Chairman and Chief Executive Officer.
About CAST Surgical
CAST is a US-based, global medical
device company that designs, develops, manufactures, and
distributes laparoscopic surgery access tools to allow precision,
mitigate risk, and standardize efficient timely access. Our mission
is to bring to the medical community superior and innovative
solutions that provide unique value, both clinically and
economically. More information is available at
www.castsurgical.com.
About AAGL
AAGL is the largest medical society focused
on gynecologic surgery, with an international membership of over
7,100 physicians and healthcare providers committed to advancing
minimally invasive gynecologic surgery (MIGS). AAGL's Annual Global
Congress is the premier scientific program that provides the
world's finest gynecologic surgeons with the latest education and
best practices in MIGS.
Contacts
For investor inquiries please contact:
Thomas A. Gordy, Chairman and Chief
Executive Officer, tgordy@castsurgical.com
For media inquiries please contact:
CAST Surgical, +1-770-328-6642
www.castsurgical.com
Logo -
https://mma.prnewswire.com/media/2478953/CAST_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/cast-surgical-chosen-to-unveil-breakthrough-clinical-follow-up-data-at-2024-aagl-global-congress-on-migs-302218980.html